𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Descriptive epidemiology of prostate cancer in metropolitan detroit

✍ Scribed by Jimmy D. Taylor; Talmage M. Holmes; G. Marie Swanson


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
389 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Risk of multiple primary cancers in pros
✍ Pawlish, Karen S.; Schottenfeld, David; Severson, Richard; Montie, James E. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

## Background: Patterns of excess risk for second primary cancers (spc) in prostate cancer patients have been observed for urinary bladder, other sites in the urinary tract, and hematolymphopoietic tissues in several, but not all, previously reported cohort studies. ## Methods: The risk of spc wa

Descriptive epidemiology of cerebral gli
✍ AgnΓ¨s Fleury; FranΓ§ois Menegoz; Pascale Grosclaude; Jean-Pierre Daures; Michel H πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

French cancer registries. The incidence rates by histologic type, age, and gender

Epidemiologic determinants of clinically
✍ Margaret R. Spitz; Sara S. Strom; Yuko Yamamura; Patricia Troncoso; Richard J. B πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 67 KB πŸ‘ 2 views

While tumor volume and Gleason scores are the best available prognostic indicators for prostate cancer, contemporary predictive methods are unable to identify which men with Gleason scores of 7 have clinically insignificant tumors that will not progress and which men will develop highly aggressive p

Trends in the stage specific incidence o
✍ Kendra L. Schwartz; Richard K. Severson; James G. Gurney; James E. Montie πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 490 KB πŸ‘ 1 views

## BACKGROUND. Much of the recent increase in prostate carcinoma incidence has been attributed to screening with prostate specific antigen (PSA). Controversy exists as to whether this screening will ultimately impact prostate carcinoma mortality. Until adequate time elapses since PSA screening bec